Rigrodsky & Long, P.A.:
  • Do you, or did you, own shares of Northwest Biotherapeutics, Inc. (NASDAQ CM: NWBO )?
  • Did you purchase your shares between March 8, 2013 and August 20, 2015, inclusive?
  • Did you lose money in your investment?

Rigrodsky & Long, P.A. reminds shareholders of Northwest Biotherapeutics, Inc. ("Northwest Biotherapeutics" or the "Company") (NASDAQ CM: NWBO) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

A complaint was filed in the United States District Court for the District of Maryland on behalf of all persons or entities that purchased the common stock of Northwest Biotherapeutics between March 8, 2013 and August 20, 2015, inclusive (the "Class Period"), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the "Complaint"). If you wish to serve as lead plaintiff, you must move the Court no later than October 26, 2015.

If you purchased shares of Northwest Biotherapeutics during the Class Period, or purchased shares prior to the Class Period and still hold Northwest Biotherapeutics, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to info@rl-legal.com; or at: http://rigrodskylong.com/investigations/northwest-biotherapeutics-inc-nwbo.

A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Attorney advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151015006851/en/

Copyright Business Wire 2010